Eli Lilly and Company· @EliLillyandCo · X·· 2026-08-28AI 评分22
AI 导读
礼来的注射类体重管理药物与未接受治疗者相比，随时间推移与更低的医疗成本相关。阅读这项新研究的更多内容：https://go.lilly.com/q5mxur
正文
Lilly’s injectable weight management medicine was linked to lower healthcare costs over time compared to those not on treatment. Read more from this new study: https://go.lilly.com/q5mxur
来源：Eli Lilly and Company · x.com